232 related articles for article (PubMed ID: 12852341)
1. [Management of nausea, vomiting and anorexia due to anticancer agents].
Shimada K; Taguchi S
Gan To Kagaku Ryoho; 2003 Jun; 30(6):760-4. PubMed ID: 12852341
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S
Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087
[TBL] [Abstract][Full Text] [Related]
3. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
Cunningham RS
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies of oral antiemetic drugs on delayed emesis induced by cancer chemotherapy].
Sawaguchi K; Yabushita H; Tsukada H; Yamada H; Noguchi M; Nakanishi M
Gan To Kagaku Ryoho; 1999 Jan; 26(1):117-23. PubMed ID: 9987507
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics].
Sawada T; Matsumura T; Mugishima H; Kaneko M; Ohira M; Sugimoto T; Onuma N; Sakurai M; Takeda T
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1295-304. PubMed ID: 10478183
[TBL] [Abstract][Full Text] [Related]
6. [New developments in the treatment of nausea and vomiting caused by chemotherapy].
de Wit R; van Alphen MM
Ned Tijdschr Geneeskd; 2003 Apr; 147(15):690-4. PubMed ID: 12722531
[TBL] [Abstract][Full Text] [Related]
7. Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting.
Münstedt K; Müller H; Blauth-Eckmeyer E; Stenger K; Zygmunt M; Vahrson H
Br J Cancer; 1999 Feb; 79(3-4):637-9. PubMed ID: 10027342
[TBL] [Abstract][Full Text] [Related]
8. [Effect of steroid on antiemetic for side effect of anticancer chemotherapy].
Nakamura Y; Momokawa K; Sasaki T; Sakayauchi T; Watanabe T; Mikami T; Matsumoto T
Gan To Kagaku Ryoho; 2005 Mar; 32(3):401-4. PubMed ID: 15791827
[TBL] [Abstract][Full Text] [Related]
9. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics.
Morrow GR; Roscoe JA; Kirshner JJ; Hynes HE; Rosenbluth RJ
Support Care Cancer; 1998 May; 6(3):244-7. PubMed ID: 9629877
[TBL] [Abstract][Full Text] [Related]
10. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of combination with granisetron and methylprednisolone for nausea, vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia--a randomized comparative trial between granisetron alone and granisetron plus methylprednisolone].
Ono K; Uchida I; Uno N; Ohno E; Hirota K; Nakayama T; Ohtuka E; Saburi Y; Kikuchi H; Nasu M
Gan To Kagaku Ryoho; 1999 May; 26(6):821-8. PubMed ID: 10410152
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
Navari RM
J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
[TBL] [Abstract][Full Text] [Related]
13. Antiemetic drugs.
Cranwell-Bruce L
Medsurg Nurs; 2009; 18(5):309-13; quiz 314. PubMed ID: 19927970
[No Abstract] [Full Text] [Related]
14. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
Mahesh R; Perumal RV; Pandi PV
Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
[TBL] [Abstract][Full Text] [Related]
15. [A randomized trial of Zudan in the prophylaxis of nausea and vomiting induced by cisplatin].
Huang J; Wang Z; Zhou L
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):153-4. PubMed ID: 10920971
[TBL] [Abstract][Full Text] [Related]
16. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
17. Optimising antiemetic therapy: what are the problems and how can they be overcome?
Aapro M
Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
[TBL] [Abstract][Full Text] [Related]
18. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
[TBL] [Abstract][Full Text] [Related]
19. [Effect of diazepam on delayed nausea and vomiting caused by anticancer agents].
Tong FZ; Zhang JQ; Qiao XM; Mao YC; Meng FY; Liu HJ; Hui S; Zhu FX; Shu W; Hong J
Gan To Kagaku Ryoho; 1998 Feb; 25(3):391-5. PubMed ID: 9492833
[TBL] [Abstract][Full Text] [Related]
20. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]